ストックスクリーナーアプリを入手
1.21
0.82%
-0.01
アフターアワーズ：
1.24
0.03
+2.48%
前日終値:
$1.22
開ける：
$1.22
24時間の取引高:
43,131
Relative Volume:
0.18
時価総額：
$38.61M
収益：
$4.66M
当期純損益:
$-42.56M
株価収益率:
-0.9758
EPS:
-1.24
ネットキャッシュフロー:
$-22.51M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-5.47%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
-9.02%
1日の値動き範囲:
$1.18
$1.23
1週間の範囲:
$1.17
$1.24
52週間の値動き範囲:
$1.00
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
名前
Co Diagnostics Inc
セクター
電話
(801) 278-9769
住所
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-12 | ダウングレード | Sidoti | Buy → Neutral |
| 2021-12-29 | 開始されました | Sidoti | Buy |
| 2021-03-29 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-05-20 | アップグレード | Maxim Group | Hold → Buy |
| 2020-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
Co Diagnostics Inc (CODX) 最新ニュース
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 - WV News
Analyzing Insulet (NASDAQ:PODD) and Co-Diagnostics (NASDAQ:CODX) - Defense World
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Relea - GuruFocus.com
Is Co-Diagnostics (NASDAQ:CODX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - BioSpace
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 - PR Newswire
Some of the Key Players in the Emerging Infectious Disease Diagnostics Market : - InsightAce Analytic
Co-Diagnostics Inc (CODX) Q2 2024 Earnings Call Highlights: Revenue Surge Amidst Regulatory Hurdles - Yahoo Finance
The APAC Coronavirus Test Kits Market is projected to grow by USD 2.87 Billion (2024-2028), driven by increased availability of test kits and AI-powered market evolutionTechnavio - Lelezard
In-vitro Diagnostics Kit Market is Expected to See a Growth of 4.40% CAGR from 2024 to 2034 | Future Market Insights, Inc. – Market Research Blog - Market Research Blog
Coronavirus Test Kits Market in North America to Shrink by USD 1.41 Billion (2024-2028) as Integration with Routine Healthcare Evolves, AI-Powered Report by Technavio - The Malaysian Reserve
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - StockTitan
Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 30.9% in September - Defense World
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - StockTitan
Co-Diagnostics (CODX) Price Target Increased by 50.00% to 3.06 - MSN
Co-Diagnostics Inc Inc. (CODX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Co-Diagnostics' Mpox test effective against new clade - Investing.com
Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test - TipRanks
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - PR Newswire
Multiplex Assay Market to Soar USD 6.75 Bn by 2034: Projections Show 4x Growth Driven by Innovations in Diagnostics and Drug Discovery - BioSpace
How does Co-Diagnostics Inc (CODX) change from a tortoise to a hare? - SETE News
Balance Sheet Insights: Co-Diagnostics Inc (CODX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Co-Diagnostics Inc (CODX) shows promising results - US Post News
Co-Diagnostics sees shareholder backing in annual meeting votes By Investing.com - Investing.com South Africa
Co-Diagnostics sees shareholder backing in annual meeting votes - Investing.com
Closing Bell Recap: Co-Diagnostics Inc (CODX) Ends at 1.58, Reflecting a -9.71 Downturn - The Dwinnex
Co-Diagnostics Inc (CODX) presents a great opportunity, but the stock is slightly undervalued - US Post News
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? - Yahoo Finance
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13 - BioSpace
2024 Report | United States Autoimmune Disease Diagnostics - GlobeNewswire
Financial Metrics Unveiled: Co-Diagnostics Inc (CODX)’s Key Ratios in the Spotlight - The Dwinnex
Views of Wall Street’s Leading Experts on Co-Diagnostics Inc - SETE News
Co-Diagnostics (NASDAQ:CODX) adds US$8.6m to market cap in the past 7 days, though investors from three years ago are still down 87% - Simply Wall St
Co-Diagnostics Inc Inc. (CODX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Genolution triples mpox diagnostic kit production capacity with completion of new Songdo facility - KBR
Will Co-Diagnostics Inc (CODX) meet earnings estimates this quarter? - US Post News
Co-Diagnostics stock hits 52-week high at $1.73 amid market rally - Investing.com Canada
Short Interest in Co-Diagnostics, Inc. (NASDAQ:CODX) Drops By 12.3% - Defense World
Co-Diagnostics (FRA:C97) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
Co-Diagnostics stock hits 52-week high at $1.73 amid market rally By Investing.com - Investing.com South Africa
CODXCo-Diagnostics, Inc. Latest Stock News & Market Updates - StockTitan
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - PR Newswire
Co-Diagnostics, Inc. (NASDAQ:CODX) Expected to Post Q3 2024 Earnings of ($0.33) Per Share - Defense World
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast - Longview News-Journal
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast - Longview News-Journal
Co-Diagnostics (NASDAQ:CODX) Price Target Cut to $1.50 by Analysts at HC Wainwright - Defense World
Earnings call: Co-Diagnostics Q2 earnings reflect growth and optimism By Investing.com - Investing.com Australia
Earnings call: Co-Diagnostics Q2 earnings reflect growth and optimism - Investing.com
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2024 Earnings Call Transcript - Insider Monkey
Co-Diagnostics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Co Diagnostics Inc (CODX) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
1.00%
大文字化:
|
ボリューム (24 時間):